Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 09-2022 | 08-2022 | 05-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,733 | -180,360 | N/A | -133,643 | -87,934 |
| Depreciation Amortization | 2,362 | 11,234 | N/A | 8,847 | 5,878 |
| Accounts receivable | N/A | 6,000 | N/A | 6,000 | 6,000 |
| Accounts payable and accrued liabilities | 400 | 85 | N/A | 984 | 1,747 |
| Other Working Capital | -18,618 | -19,022 | N/A | -17,100 | -6,544 |
| Other Operating Activity | 8,137 | 22,256 | 0 | 13,060 | 5,309 |
| Operating Cash Flow | $-48,452 | $-159,807 | $N/A | $-121,852 | $-75,544 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,277 | -12,244 | N/A | -9,679 | -6,261 |
| Purchase Of Investment | -22,642 | -239,366 | N/A | -212,455 | -80,031 |
| Sale Of Investment | 40,987 | 278,808 | N/A | 194,324 | 121,558 |
| Investing Cash Flow | $16,068 | $27,198 | $N/A | $-27,810 | $35,266 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,481 | 22,433 | N/A | 22,385 | 1,920 |
| Other Financing Activity | 0 | 94,759 | 0 | 94,942 | 0 |
| Financing Cash Flow | $1,481 | $117,192 | $N/A | $117,327 | $1,920 |
| Beginning Cash Position | 65,375 | 80,792 | N/A | 80,792 | 80,792 |
| End Cash Position | 34,472 | 65,375 | N/A | 48,457 | 42,434 |
| Net Cash Flow | $-30,903 | $-15,417 | $N/A | $-32,335 | $-38,358 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,452 | -159,807 | N/A | -121,852 | -75,544 |
| Capital Expenditure | -2,277 | -12,244 | N/A | -9,679 | -6,261 |
| Free Cash Flow | -50,729 | -172,051 | 0 | -131,531 | -81,805 |